Assessment of two new molecular methods for identification of Candida parapsilosis sensu lato species

Journal of Clinical Microbiology

Volumn 49, Issue 9, 2011, Pages 3257-3261

  Garcia Effron, Guillermo ^a,c   Canton, Emilia ^b   Pemán, Javier ^b   Dilger, Amanda ^a   Romá, Eva ^b   Perlin, David S ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

INTERNAL TRANSCRIBED SPACER 1; INTERNAL TRANSCRIBED SPACER 2;

ARTICLE; BLOOD CULTURE; BLOODSTREAM INFECTION; CANDIDA PARAPSILOSIS; CONTROLLED STUDY; FKS1 GENE; FUNGAL GENE; FUNGAL STRAIN; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; GENE AMPLIFICATION; INTERMETHOD COMPARISON; MOLECULAR BEACON; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; SEQUENCE ANALYSIS; STRAIN DIFFERENCE; STRAIN IDENTIFICATION;

CANDIDA; CANDIDEMIA; DNA PRIMERS; DNA, FUNGAL; DNA, RIBOSOMAL SPACER; FUNGAL PROTEINS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MOLECULAR SEQUENCE DATA; MYCOLOGY; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

CANDIDA PARAPSILOSIS;

EID: 80052203445     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00508-11     Document Type: Article

References (30)

1. Asadzadeh, M., S. Ahmad, N. Al Sweih, and Z. U. Khan. 2009. Rapid molecular differentiation and genotypic heterogeneity among Candida parapsilosis and Candida orthopsilosis strains isolated from clinical specimens in Kuwait. J. Med. Microbiol. 58:745-752.
2. Borman, A. M., et al. 2009. Pyrosequencing analysis of 20 nucleotides of internal transcribed spacer 2 discriminates Candida parapsilosis, Candida metapsilosis, and Candida orthopsilosis. J. Clin. Microbiol. 47:2307-2310.
3. Borst, A., et al. 2003. Use of amplified fragment length polymorphism analysis to identify medically important Candida spp., including C. dubliniensis. J. Clin. Microbiol. 41:1357-1362.
4. Cantón, E., A. Espinel-Ingroff, J. Peman, and L. del Castillo. 2010. In vitro fungicidal activities of echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis evaluated by time-kill studies. Antimicrob. Agents Chemother. 54:2194-2197.
5. Cassone, A., et al. 1995. Biotype diversity of Candida parapsilosis and its relationship to the clinical source and experimental pathogenicity. J. Infect. Dis. 171:967-975.
6. Diekema, D. J., et al. 2009. In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods. J. Clin. Microbiol. 47:3170-3177.
7. Gácser, A., W. Schafer, J. S. Nosanchuk, S. Salomon, and J. D. Nosanchuk. 2007. Virulence of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis in reconstituted human tissue models. Fungal Genet. Biol. 44:1336-1341.
8. Garcia-Effron, G., et al. 2008. Rapid detection of triazole antifungal resistance in Aspergillus fumigatus. J. Clin. Microbiol. 46:1200-1206.
9. Garcia-Effron, G., S. K. Katiyar, S. Park, T. D. Edlind, and D. S. Perlin. 2008. A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility. Antimicrob. Agents Chemother. 52:2305-2312.
10. Gomez-Lopez, A., et al. 2008. Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain. Antimicrob. Agents Chemother. 52:1506-1509.
11. Goncalves, S. S., et al. 2010. Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil. Clin. Microbiol. Infect. 16:885-887.
12. Kato, M., M. Ozeki, A. Kikuchi, and T. Kanbe. 2001. Phylogenetic relationship and mode of evolution of yeast DNA topoisomerase II gene in the pathogenic Candida species. Gene 272:275-281. (Pubitemid 32695420)
13. Lehmann, P. F., D. Lin, and B. A. Lasker. 1992. Genotypic identification and characterization of species and strains within the genus Candida by using random amplified polymorphic DNA. J. Clin. Microbiol. 30:3249-3254.
14. Lin, D., L. C. Wu, M. G. Rinaldi, and P. F. Lehmann. 1995. Three distinct genotypes within Candida parapsilosis from clinical sources. J. Clin. Microbiol. 33:1815-1821.
15. Lockhart, S. R., S. A. Messer, M. A. Pfaller, and D. J. Diekema. 2008. Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis. J. Clin. Microbiol. 46:2659-2664.
16. Lockhart, S. R., S. A. Messer, M. A. Pfaller, and D. J. Diekema. 2008. Lodderomyces elongisporus masquerading as Candida parapsilosis as a cause of bloodstream infections. J. Clin. Microbiol. 46:374-376.
17. Mirhendi, H., et al. 2010. Molecular screening for Candida orthopsilosis and Candida metapsilosis among Danish Candida parapsilosis group blood culture isolates: proposal of a new RFLP profile for differentiation. J. Med. Microbiol. 59:414-420.
18. Nosek, J., L. Tomaska, A. Rycovska, and H. Fukuhara. 2002. Mitochondrial telomeres as molecular markers for identification of the opportunistic yeast pathogen Candida parapsilosis. J. Clin. Microbiol. 40:1283-1289.
19. Orsi, C. F., B. Colombari, and E. Blasi. 2010. Candida metapsilosis as the least virulent member of the 'C. parapsilosis ' complex. Med. Mycol. 48:1024-1033.
20. Roy, B., and S. A. Meyer. 1998. Confirmation of the distinct genotype groups within the form species Candida parapsilosis. J. Clin. Microbiol. 36:216-218.
21. Sabino, R., et al. 2010. New polymorphic microsatellite markers able to distinguish among Candida parapsilosis sensu stricto isolates. J. Clin. Microbiol. 48:1677-1682.
22. Scherer, S., and D. A. Stevens. 1987. Application of DNA typing methods to epidemiology and taxonomy of Candida species. J. Clin. Microbiol. 25:675-679.
23. Silva, A. P., I. M. Miranda, C. Lisboa, C. Pina-Vaz, and A. G. Rodrigues. 2009. Prevalence, distribution, and antifungal susceptibility profiles of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a tertiary care hospital. J. Clin. Microbiol. 47:2392-2397.
24. Szabó, Z., et al. 2009. In vitro efficacy of 5 antifungal agents against Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis as determined by time-kill methodology. Diagn. Microbiol. Infect. Dis. 64:283-288.
25. Tavanti, A., A. D. Davidson, N. A. R. Gow, M. C. J. Maiden, and F. C. Odds. 2005. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J. Clin. Microbiol. 43:284-292.
26. Tavanti, A., L. A. Hensgens, E. Ghelardi, M. Campa, and S. Senesi. 2007. Genotyping of Candida orthopsilosis clinical isolates by amplification fragment length polymorphism reveals genetic diversity among independent isolates and strain maintenance within patients. J. Clin. Microbiol. 45:1455-1462.
27. Tay, S. T., S. L. Na, and J. Chong. 2009. Molecular differentiation and antifungal susceptibilities of Candida parapsilosis isolated from patients with bloodstream infections. J. Med. Microbiol. 58:185-191.
28. van Asbeck, E., K. V. Clemons, M. Martinez, A. J. Tong, and D. A. Stevens. 2008. Significant differences in drug susceptibility among species in the Candida parapsilosis group. Diagn. Microbiol. Infect. Dis. 62:106-109.
29. Varga, I., et al. 2008. Comparison of killing activity of caspofungin against Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis. J. Antimicrob. Chemother. 62:1466-1468.
30. White, T. J., T. D. Bruns, S. B. Lee, and J. W. Taylor. 1990. Amplification and direct sequencing of fungal rRNA genes for phylogenetics, p. 315-322. In M. A. Innis, D. H. Gelfand, J. J. Sninsky, and T. J. White (ed.), PCR protocols: a guide to methods and applications. Academic Press, Inc., San Diego, CA.